Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$59.13

1.57 (2.73%)

05:16
04/24/19
04/24
05:16
04/24/19
05:16

Piper calls Merit Medical a must own name after Q1 beat

After a "robust" start to 2019, Merit Medical Systems is a mid-cap name that investors need to own, Piper Jaffray analyst Matt O'Brien writes in a research note. He believes the company can deliver some of the best top- and bottom-line growth in med tech in the coming years. Revenue from the recently completed Cianna acquisition helped deliver some of the revenue upside in Q1, but the organic growth in the business remains strong, says O'Brien. He reiterates an Overweight rating on Merit Medical with a $75 price target and says the stock remains his favorite mid-cap name.

  • 07

    May

  • 08

    May

  • 23

    May

MMSI Merit Medical
$59.13

1.57 (2.73%)

12/17/18
PIPR
12/17/18
NO CHANGE
Target $75
PIPR
Overweight
Merit Medical acquisition 'another prudent solid tuck-in,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien views Merit Medical Systems' acquisition of Vascular Insights as "another prudent solid tuck-in" for the company. Vascular's assets, used for the treatment of varicose veins, complement an "already substantial" vascular portfolio and should allows Merit's "large global salesforce" to address this $700M global market, O'Brien tells investors in a research note. He reiterates an Overweight rating on the shares with a $75 price target.
12/18/18
PIPR
12/18/18
NO CHANGE
PIPR
Piper lays out top Medical Technology picks heading into 2019
Piper Jaffray analyst Matt O'Brien tells investors to hold onto Medical Technology stocks into 2019. Multiples are unlikely to increase meaningfully next year, but they should hold given the continued solid fundamentals and strong new product cycles, O'Brien tells investors in a research note after taking a close look at the Med Tech sector. He believes Align Technology (ALGN), Inogen (INGN) and Nuvectra (NVTR) "could provide considerable alpha to investors willing to step up to the plate and buy now." Secondly, the analyst thinks Intuitive Surgical (ISRG) and Merit Medical (MMSI) "could provide a defensive bet in volatile markets."
02/11/19
PIPR
02/11/19
NO CHANGE
Target $75
PIPR
Overweight
Piper sees 2018 deals pushing Merit Medical shares 'much higher'
Merit Medical Systems executed four transactions, including one partnership with NinePoint, in 2018, representing capital deployed of approximately $380M, or 13% of its market capitalization, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst says Piper is "big fans" of the deals, with Cianna his favorite given the revenue growth outlook, along with the earnings power it could bring. Collectively he believes the acquired assets will add nearly 200 basis points to Merit Medical's organic revenue growth in 2020 and drive earnings above consensus. This will become clearer to investors in the coming quarters, "pushing shares much higher compared to current levels," says O'Brien. He keeps an Overweight rating on Merit Medical Systems with a $75 price target.
03/25/19
PIPR
03/25/19
NO CHANGE
PIPR
Piper sees six 'quality' Med Tech names whose stocks haven't rallied
Medical Technology stocks have rebounded quickly in Q1 following a challenging Q4 of 2018 as the combination of solid year-end results and compelling outlooks for next year have led investors back into the names, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst, however, has identified six "quality" names that have not participated in the Q1 share appreciation, "despite consistently delivering beat-and-raises." The basket of stocks include Abiomed (ABMD), Merit Medical (MMSI), AtriCure (ATRC), Neuronetics (STIM), SeaSpine (SPNE) and Nuvectra (NVTR).

TODAY'S FREE FLY STORIES

SPOT

Spotify

$149.94

1.77 (1.19%)

, AAPL

Apple

$199.39

0.62 (0.31%)

11:44
06/24/19
06/24
11:44
06/24/19
11:44
Periodicals
Apple hits back at Spotify's claims of unfair App Store treatment, AI reports »

Apple (AAPL) is hitting…

SPOT

Spotify

$149.94

1.77 (1.19%)

AAPL

Apple

$199.39

0.62 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

OXFD

Oxford Immunotec

$13.88

-0.22 (-1.56%)

11:37
06/24/19
06/24
11:37
06/24/19
11:37
Hot Stocks
Oxford Immunotec appoints Patrick Balthrop, Sr. as Chairman »

Oxford Immunotec…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.99

1.82 (1.23%)

, DE

Deere

$167.23

2.94 (1.79%)

11:33
06/24/19
06/24
11:33
06/24/19
11:33
On The Fly
Spotify downgrade, Deere upgrade among today's top analyst calls »

Check out today's top…

SPOT

Spotify

$149.99

1.82 (1.23%)

DE

Deere

$167.23

2.94 (1.79%)

AGCO

Agco

$76.63

1.92 (2.57%)

IP

International Paper

$42.49

-1.13 (-2.59%)

OXY

Occidental Petroleum

$49.84

-0.78 (-1.54%)

APC

Anadarko

$70.20

-0.17 (-0.24%)

OAS

Oasis Petroleum

$5.45

-0.27 (-4.72%)

SHOP

Shopify

$315.91

-10.77 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 10

    Jul

  • 17

    Jul

  • 27

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

FB

Facebook

$193.42

2.26 (1.18%)

11:30
06/24/19
06/24
11:30
06/24/19
11:30
Options
Lots of likes for short-term Facebook upside calls »

Lots of likes for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

SIG

Signet Jewelers

$17.49

-0.13 (-0.74%)

11:25
06/24/19
06/24
11:25
06/24/19
11:25
Options
Signet Jewelers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$17.18

-0.23 (-1.32%)

11:24
06/24/19
06/24
11:24
06/24/19
11:24
Conference/Events
Tivity Health management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 14

    Aug

  • 15

    Aug

11:20
06/24/19
06/24
11:20
06/24/19
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/24/19
06/24
11:17
06/24/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/24/19
06/24
11:16
06/24/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$100.87

-1.29 (-1.26%)

11:15
06/24/19
06/24
11:15
06/24/19
11:15
Options
UPS put volume heavy and directionally bearish »

Bearish flow noted in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

, PFE

Pfizer

$43.59

-0.09 (-0.21%)

11:11
06/24/19
06/24
11:11
06/24/19
11:11
On The Fly
Before the Move: Watch Sarepta ahead of Pfizer's DMD gene therapy data »

Ahead of the Parent…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

PFE

Pfizer

$43.59

-0.09 (-0.21%)

SLDB

Solid Biosciences

$4.91

-0.07 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Aug

  • 28

    Aug

  • 16

    Sep

GLW

Corning

$33.15

-0.1 (-0.30%)

11:08
06/24/19
06/24
11:08
06/24/19
11:08
Recommendations
Corning analyst commentary at JPMorgan »

Drop in LCD TV panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$81.18

1.87 (2.36%)

11:05
06/24/19
06/24
11:05
06/24/19
11:05
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

, CELG

Celgene

$94.16

-4.76 (-4.81%)

10:59
06/24/19
06/24
10:59
06/24/19
10:59
Periodicals
Bristol-Myers' merger headaches could be 'contagious,' STAT News says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

CELG

Celgene

$94.16

-4.76 (-4.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:54
06/24/19
06/24
10:54
06/24/19
10:54
Upgrade
Line Corp. rating change  »

Line Corp. now fairly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$42.65

0.15 (0.35%)

10:50
06/24/19
06/24
10:50
06/24/19
10:50
Options
Heavy call volume in China Largecap ETF adjusts existing position »

Heavy call volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$1.24

0.015 (1.22%)

10:49
06/24/19
06/24
10:49
06/24/19
10:49
Hot Stocks
PAVmed announces FDA 510(k) clearance for EsoCheck »

PAVmed announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:46
06/24/19
06/24
10:46
06/24/19
10:46
Upgrade
Line Corp. rating change at Goldman Sachs »

Line Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBX

Dropbox

$25.29

0.3 (1.20%)

10:45
06/24/19
06/24
10:45
06/24/19
10:45
Options
Dropbox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
06/24/19
06/24
10:45
06/24/19
10:45
General news
U.S. Dallas Fed manufacturing index dropped another 6.8 points to -12.1 in June »

U.S. Dallas Fed…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

, ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

10:41
06/24/19
06/24
10:41
06/24/19
10:41
Hot Stocks
Amazon Business launches Amazon Professional Beauty Store »

Amazon (AMZN) has…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

SBH

Sally Beauty

$14.65

-0.14 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.